AI Science Tracker
EN

Pathology-guided neural modeling proposes six Alzheimer subtypes

Wake Forest University · 31 Jul 2023 · medicine

Discovery

Pathology-guided neural modeling proposes six Alzheimer subtypes

Source check: Source checked. Not independent scientific confirmation.

Finding: PSSN combined reaction-diffusion biomarker trajectories with an LSTM and neural subtype assignments in 320 selected ADNI participants. It proposed six subtypes with different cognitive profiles. Cognitive scores also guided fitting and selection of subtype number, so these are exploratory model-dependent groups, without an independent subtype ground truth, causal disease mechanisms or demonstrated treatment utility.

Technology: PSSN; LSTM; fully connected neural networks

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
An LSTM encodes modeled biomarker trajectories and neural networks jointly learn subtype probabilities and clinical-score relationships.
Test and result
Retrospective multimodal longitudinal data, comparison with clustering baselines and cognitive-profile analyses.
Limitation / still unknown
Independent subtype replication and biological ground truth remain unestablished; clinical-profile-based model selection limits independent validation claims.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10828102/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant Methods/results/limitations and exact front/canonical identity; current primary PubMed linked correction/retraction metadata checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.